TicoVac 1.2 ug/.25mL (Tick-Borne Encephalitis Vaccine INJECTION) 1.2 ug/.25mL

TicoVac 1.2 µg/0.25 mL works by stimulating the immune system to produce antibodies against the tick-borne encephalitis virus. The vaccine contains inactivated virus particles that prompt the body to recognize and fight the virus, thereby providing immunity against future infections.

The usual dose of TicoVac 1.2 µg/0.25 mL is determined by a healthcare provider. The primary vaccination course involves three doses, with the second dose given 1 to 3 months after the first dose and the third dose given 5 to 12 months after the second dose.

The safety of TicoVac 1.2 µg/0.25 mL during pregnancy has not been fully established. It is important to inform your healthcare provider if you are pregnant or plan to become pregnant before receiving the vaccine.

To order TicoVac 1.2 µg/0.25 mL from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will reply with pricing, availability, shipping and the import paperwork.

TicoVac 1.2 µg/0.25 mL is one of the vaccines available for the prevention of tick-borne encephalitis. It is important to consult with a healthcare provider to determine the most suitable vaccine based on individual health conditions and local availability.

TicoVac 1.2 µg/0.25 mL should be stored at 2-8°C, refrigerated, protected from light, and not frozen or shaken. Proper storage is crucial to maintain the vaccine's effectiveness.

TicoVac 1.2 µg/0.25 mL is typically administered into the muscle of the upper arm by a healthcare professional. It should not be injected into a blood vessel.

The most serious risks associated with TicoVac 1.2 µg/0.25 mL include severe allergic reactions. Individuals with a history of severe allergic reactions to previous doses of TicoVac should avoid this vaccine.

TicoVac 1.2 µg/0.25 mL should not be given to individuals with a history of severe allergic reactions to previous doses of TicoVac. It is also important to inform your healthcare provider about any other medical conditions or medications you are taking before receiving the vaccine.